Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Eva Anette EngelhardtEVP, President, CDG | Bio-Rad LaboratoriesBIO | Open-market sale | 05/11 | 05/13 | 550 sh | $246.54 | $135,597 | −61.4% |
James BarryEVP, President, LSG | Bio-Rad LaboratoriesBIO | Open-market sale | 25/11/06 | 25/11/10 | 699.87 sh | $306.18 | $214,286.2 | −57.9% |
Michael CrowleyEVP, GBL Commercial Operations | Bio-Rad LaboratoriesBIO | Open-market sale | 25/03/14 | 25/03/18 | 3,000 sh | $247.06 | $741,180 | −26.9% |
Andrew J. LastEVP, COO | Bio-Rad LaboratoriesBIO | Open-market sale | 24/09/06 | 24/09/10 | 3,000 sh | $329.94 | $989,820 | −28.4% |
James BarryEVP, President, LSG | Bio-Rad LaboratoriesBIO | Open-market sale | 24/09/04 | 24/09/04 | 623 sh | $330.49 | $205,895.27 | −81.0% |
Michael CrowleyEVP, GBL Commercial Operations | Bio-Rad LaboratoriesBIO | Open-market sale | 24/06/13 | 24/06/14 | 369 sh | $281.91 | $104,024.79 | −5.3% |
Steven D. Schwartz10% Owner | Bio-Rad LaboratoriesBIO | Open-market sale | 23/05/03 | 24/05/01 | 320 sh | $463.86 | $148,435.2 | −17.6% |
Timothy S. ErnstEVP, General Counsel & Sec | Bio-Rad LaboratoriesBIO | Open-market sale | 24/02/28 | 24/02/29 | 2,500 sh | $330.55 | $826,375 | −42.4% |
Michael CrowleyEVP, GBL Commercial Operations | Bio-Rad LaboratoriesBIO | Open-market sale | 24/02/27 | 24/02/28 | 3,000 sh | $336.00 | $1,008,000 | −30.2% |
Dara WrightEVP, President, CDG | Bio-Rad LaboratoriesBIO | Open-market sale | 23/12/12 | 23/12/12 | 1,200 sh | $299.16 | $358,992 | −44.5% |
Michael CrowleyEVP, GBL Commercial Operations | Bio-Rad LaboratoriesBIO | Open-market sale | 23/11/28 | 23/11/28 | 642 sh | $305.10 | $195,874.2 | −8.5% |
Bio-Rad LaboratoriesBIO | Open-market sale | 23/08/30 | 23/08/31 | 2,350 sh3 trades | $395.60avg. | $929,666.76 | −49.3% | |
Timothy S. ErnstEVP, General Counsel & Sec | Bio-Rad LaboratoriesBIO | Open-market sale | 23/08/23 | 23/08/23 | 300 sh | $384.69 | $115,407 | −11.0% |
Michael CrowleyEVP, GBL Commercial Operations | Bio-Rad LaboratoriesBIO | Open-market sale | 23/06/15 | 23/06/16 | 500 sh | $379.39 | $189,695 | −7.6% |
Bio-Rad LaboratoriesBIO | Open-market sale | 23/06/06 | 23/06/07 | 198.35 sh2 trades | $368.30avg. | $73,051.98 | −100.0% | |
Bio-Rad LaboratoriesBIO | Open-market sale | 23/03/08 | 23/03/08 | 1,746 sh2 trades | $486.43avg. | $849,299.94 | −39.5% |